Cryosa Completes $8.25 Million in Series A-2 Funding for Further Development of Breakthrough, Minimally Invasive Treatment for Obstructive Sleep Apnea View more
Sandstone Diagnostics Raises Additional Series A Financing to Accelerate Zero Delay™ Plasma Technology Development View more
SilkTech Biopharmaceuticals’ IND Submission Cleared by FDA; Phase 2 Clinical Trial Initiated for Patients with Dry Eye Disease View more
